USA Biosimilar Testing and Development Services Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Biosimilar Testing and Development Services market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Biosimilar Testing and Development Services market. Detailed analysis of key players, along with key growth strategies adopted by Biosimilar Testing and Development Services industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Medistri

    • SGS

    • Sigma-Aldrich

    • Pharmaceutical Product Development

    • Charles River Laboratories

    • Intertek Group

    • Source BioScience

    • Eurofins Scientific

    • Pace Analytical Services

    • Exova

    By Type:

    • Effector Binding

    • ELISA

    • Kinetic Binding Assays

    • ADCC & CDC Cell-Based Assays

    By End-User:

    • PK assay

    • Tiered Immunogenicity testing

    • NAb assays

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilar Testing and Development Services Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Biosimilar Testing and Development Services Market Size and Growth Rate of Effector Binding from 2016 to 2027

      • 1.3.2 USA Biosimilar Testing and Development Services Market Size and Growth Rate of ELISA from 2016 to 2027

      • 1.3.3 USA Biosimilar Testing and Development Services Market Size and Growth Rate of Kinetic Binding Assays from 2016 to 2027

      • 1.3.4 USA Biosimilar Testing and Development Services Market Size and Growth Rate of ADCC & CDC Cell-Based Assays from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Biosimilar Testing and Development Services Market Size and Growth Rate of PK assay from 2016 to 2027

      • 1.4.2 USA Biosimilar Testing and Development Services Market Size and Growth Rate of Tiered Immunogenicity testing from 2016 to 2027

      • 1.4.3 USA Biosimilar Testing and Development Services Market Size and Growth Rate of NAb assays from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Biosimilar Testing and Development Services Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Biosimilar Testing and Development Services Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Biosimilar Testing and Development Services Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Biosimilar Testing and Development Services Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Biosimilar Testing and Development Services Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biosimilar Testing and Development Services by Major Types

      • 3.4.1 Market Size and Growth Rate of Effector Binding

      • 3.4.2 Market Size and Growth Rate of ELISA

      • 3.4.3 Market Size and Growth Rate of Kinetic Binding Assays

      • 3.4.4 Market Size and Growth Rate of ADCC & CDC Cell-Based Assays

    4 Segmentation of Biosimilar Testing and Development Services Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biosimilar Testing and Development Services by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Biosimilar Testing and Development Services in PK assay

      • 4.4.2 Market Size and Growth Rate of Biosimilar Testing and Development Services in Tiered Immunogenicity testing

      • 4.4.3 Market Size and Growth Rate of Biosimilar Testing and Development Services in NAb assays

    5 Market Analysis by Regions

    • 5.1 USA Biosimilar Testing and Development Services Production Analysis by Regions

    • 5.2 USA Biosimilar Testing and Development Services Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Biosimilar Testing and Development Services Landscape Analysis

    • 6.1 West USA Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 6.2 West USA Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    7 South USA Biosimilar Testing and Development Services Landscape Analysis

    • 7.1 South USA Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 7.2 South USA Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    8 Middle West USA Biosimilar Testing and Development Services Landscape Analysis

    • 8.1 Middle West USA Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 8.2 Middle West USA Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    9 Northeast USA Biosimilar Testing and Development Services Landscape Analysis

    • 9.1 Northeast USA Biosimilar Testing and Development Services Landscape Analysis by Major Types

    • 9.2 Northeast USA Biosimilar Testing and Development Services Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Medistri

        • 10.1.1 Medistri Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 SGS

        • 10.2.1 SGS Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Sigma-Aldrich

        • 10.3.1 Sigma-Aldrich Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Pharmaceutical Product Development

        • 10.4.1 Pharmaceutical Product Development Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Charles River Laboratories

        • 10.5.1 Charles River Laboratories Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Intertek Group

        • 10.6.1 Intertek Group Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Source BioScience

        • 10.7.1 Source BioScience Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Eurofins Scientific

        • 10.8.1 Eurofins Scientific Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Pace Analytical Services

        • 10.9.1 Pace Analytical Services Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Exova

        • 10.10.1 Exova Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Biosimilar Testing and Development Services Market Size and Growth Rate of Effector Binding from 2016 to 2027

    • Figure USA Biosimilar Testing and Development Services Market Size and Growth Rate of ELISA from 2016 to 2027

    • Figure USA Biosimilar Testing and Development Services Market Size and Growth Rate of Kinetic Binding Assays from 2016 to 2027

    • Figure USA Biosimilar Testing and Development Services Market Size and Growth Rate of ADCC & CDC Cell-Based Assays from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Biosimilar Testing and Development Services Market Size and Growth Rate of PK assay from 2016 to 2027

    • Figure USA Biosimilar Testing and Development Services Market Size and Growth Rate of Tiered Immunogenicity testing from 2016 to 2027

    • Figure USA Biosimilar Testing and Development Services Market Size and Growth Rate of NAb assays from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Biosimilar Testing and Development Services Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Biosimilar Testing and Development Services Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Biosimilar Testing and Development Services Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Biosimilar Testing and Development Services Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Biosimilar Testing and Development Services Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Biosimilar Testing and Development Services

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biosimilar Testing and Development Services by Different Types from 2016 to 2027

    • Table Consumption Share of Biosimilar Testing and Development Services by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Effector Binding

    • Figure Market Size and Growth Rate of ELISA

    • Figure Market Size and Growth Rate of Kinetic Binding Assays

    • Figure Market Size and Growth Rate of ADCC & CDC Cell-Based Assays

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Biosimilar Testing and Development Services by Different End-Users from 2016 to 2027

    • Table Consumption Share of Biosimilar Testing and Development Services by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of PK assay

    • Figure Market Size and Growth Rate of Tiered Immunogenicity testing

    • Figure Market Size and Growth Rate of NAb assays

    • Table USA Biosimilar Testing and Development Services Production by Regions

    • Table USA Biosimilar Testing and Development Services Production Share by Regions

    • Figure USA Biosimilar Testing and Development Services Production Share by Regions in 2016

    • Figure USA Biosimilar Testing and Development Services Production Share by Regions in 2021

    • Figure USA Biosimilar Testing and Development Services Production Share by Regions in 2027

    • Table USA Biosimilar Testing and Development Services Consumption by Regions

    • Table USA Biosimilar Testing and Development Services Consumption Share by Regions

    • Figure USA Biosimilar Testing and Development Services Consumption Share by Regions in 2016

    • Figure USA Biosimilar Testing and Development Services Consumption Share by Regions in 2021

    • Figure USA Biosimilar Testing and Development Services Consumption Share by Regions in 2027

    • Table West USA Biosimilar Testing and Development Services Consumption by Types from 2016 to 2027

    • Table West USA Biosimilar Testing and Development Services Consumption Share by Types from 2016 to 2027

    • Figure West USA Biosimilar Testing and Development Services Consumption Share by Types in 2016

    • Figure West USA Biosimilar Testing and Development Services Consumption Share by Types in 2021

    • Figure West USA Biosimilar Testing and Development Services Consumption Share by Types in 2027

    • Table West USA Biosimilar Testing and Development Services Consumption by End-Users from 2016 to 2027

    • Table West USA Biosimilar Testing and Development Services Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Biosimilar Testing and Development Services Consumption Share by End-Users in 2016

    • Figure West USA Biosimilar Testing and Development Services Consumption Share by End-Users in 2021

    • Figure West USA Biosimilar Testing and Development Services Consumption Share by End-Users in 2027

    • Table South USA Biosimilar Testing and Development Services Consumption by Types from 2016 to 2027

    • Table South USA Biosimilar Testing and Development Services Consumption Share by Types from 2016 to 2027

    • Figure South USA Biosimilar Testing and Development Services Consumption Share by Types in 2016

    • Figure South USA Biosimilar Testing and Development Services Consumption Share by Types in 2021

    • Figure South USA Biosimilar Testing and Development Services Consumption Share by Types in 2027

    • Table South USA Biosimilar Testing and Development Services Consumption by End-Users from 2016 to 2027

    • Table South USA Biosimilar Testing and Development Services Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Biosimilar Testing and Development Services Consumption Share by End-Users in 2016

    • Figure South USA Biosimilar Testing and Development Services Consumption Share by End-Users in 2021

    • Figure South USA Biosimilar Testing and Development Services Consumption Share by End-Users in 2027

    • Table Middle West USA Biosimilar Testing and Development Services Consumption by Types from 2016 to 2027

    • Table Middle West USA Biosimilar Testing and Development Services Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Biosimilar Testing and Development Services Consumption Share by Types in 2016

    • Figure Middle West USA Biosimilar Testing and Development Services Consumption Share by Types in 2021

    • Figure Middle West USA Biosimilar Testing and Development Services Consumption Share by Types in 2027

    • Table Middle West USA Biosimilar Testing and Development Services Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Biosimilar Testing and Development Services Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Biosimilar Testing and Development Services Consumption Share by End-Users in 2016

    • Figure Middle West USA Biosimilar Testing and Development Services Consumption Share by End-Users in 2021

    • Figure Middle West USA Biosimilar Testing and Development Services Consumption Share by End-Users in 2027

    • Table Northeast USA Biosimilar Testing and Development Services Consumption by Types from 2016 to 2027

    • Table Northeast USA Biosimilar Testing and Development Services Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Biosimilar Testing and Development Services Consumption Share by Types in 2016

    • Figure Northeast USA Biosimilar Testing and Development Services Consumption Share by Types in 2021

    • Figure Northeast USA Biosimilar Testing and Development Services Consumption Share by Types in 2027

    • Table Northeast USA Biosimilar Testing and Development Services Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Biosimilar Testing and Development Services Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Biosimilar Testing and Development Services Consumption Share by End-Users in 2016

    • Figure Northeast USA Biosimilar Testing and Development Services Consumption Share by End-Users in 2021

    • Figure Northeast USA Biosimilar Testing and Development Services Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Medistri

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medistri

    • Figure Sales and Growth Rate Analysis of Medistri

    • Figure Revenue and Market Share Analysis of Medistri

    • Table Product and Service Introduction of Medistri

    • Table Company Profile and Development Status of SGS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SGS

    • Figure Sales and Growth Rate Analysis of SGS

    • Figure Revenue and Market Share Analysis of SGS

    • Table Product and Service Introduction of SGS

    • Table Company Profile and Development Status of Sigma-Aldrich

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sigma-Aldrich

    • Figure Sales and Growth Rate Analysis of Sigma-Aldrich

    • Figure Revenue and Market Share Analysis of Sigma-Aldrich

    • Table Product and Service Introduction of Sigma-Aldrich

    • Table Company Profile and Development Status of Pharmaceutical Product Development

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmaceutical Product Development

    • Figure Sales and Growth Rate Analysis of Pharmaceutical Product Development

    • Figure Revenue and Market Share Analysis of Pharmaceutical Product Development

    • Table Product and Service Introduction of Pharmaceutical Product Development

    • Table Company Profile and Development Status of Charles River Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Charles River Laboratories

    • Figure Sales and Growth Rate Analysis of Charles River Laboratories

    • Figure Revenue and Market Share Analysis of Charles River Laboratories

    • Table Product and Service Introduction of Charles River Laboratories

    • Table Company Profile and Development Status of Intertek Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intertek Group

    • Figure Sales and Growth Rate Analysis of Intertek Group

    • Figure Revenue and Market Share Analysis of Intertek Group

    • Table Product and Service Introduction of Intertek Group

    • Table Company Profile and Development Status of Source BioScience

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Source BioScience

    • Figure Sales and Growth Rate Analysis of Source BioScience

    • Figure Revenue and Market Share Analysis of Source BioScience

    • Table Product and Service Introduction of Source BioScience

    • Table Company Profile and Development Status of Eurofins Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eurofins Scientific

    • Figure Sales and Growth Rate Analysis of Eurofins Scientific

    • Figure Revenue and Market Share Analysis of Eurofins Scientific

    • Table Product and Service Introduction of Eurofins Scientific

    • Table Company Profile and Development Status of Pace Analytical Services

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pace Analytical Services

    • Figure Sales and Growth Rate Analysis of Pace Analytical Services

    • Figure Revenue and Market Share Analysis of Pace Analytical Services

    • Table Product and Service Introduction of Pace Analytical Services

    • Table Company Profile and Development Status of Exova

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Exova

    • Figure Sales and Growth Rate Analysis of Exova

    • Figure Revenue and Market Share Analysis of Exova

    • Table Product and Service Introduction of Exova


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.